Help
RSS
API
Feed
Maltego
Contact
Domain > ir.unicycive.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2021-10-15
3.221.176.71
(
ClassC
)
2022-02-13
3.225.74.242
(
ClassC
)
2025-07-10
34.236.86.94
(
ClassC
)
2025-09-10
35.171.180.101
(
ClassC
)
2026-01-04
52.53.61.56
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Sun, 04 Jan 2026 11:39:49 GMTServer: ApacheX-Frame-Options: SAMEORIGINStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffFeatu !DOCTYPE html>html langen> head> meta http-equivx-ua-compatible contentieedge> meta charsetutf-8> link relalternate typeapplication/rss+xml titleUnicycive Therapeutics, Inc. - Recent News hrefhttps://ir.unicycive.com/news/rss /> title>Investor Relations :: Unicycive Therapeutics, Inc. (UNCY)/title> link relcanonical hrefhttps://ir.unicycive.com>meta propertyog:url contenthttps://ir.unicycive.com>meta propertyog:site_name contentUnicycive Therapeutics, Inc.>meta propertyog:title contentInvestor Relations>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_f20b0b8d0ca77c529de77c2b2c0e64bb/unicycive/db/1929/17218/social_image_resized.jpg>meta nametwitter:card contentsummary_large_image>meta propertyog:description contentUnicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food…>meta namedescription contentUnicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food…>script typeapplication/ld+json> {@context:http://schema.org,@type:Corporation,name:Unicycive Therapeutics, Inc.,address:{@type:PostalAddress,streetAddress:4300 El Camino Real Suite 210,addressLocality:Los Altos, CA,postalCode:94022,addressCountry:},legalName:Unicycive Therapeutics, Inc.,description:Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicyciveu2019s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]